ContraFect Corporation ContraFect Corporation Nasdaq: CFRX

Navigate ContraFect Corporation

  • Home
  • About Us
    • Overview
    • Management Team
    • Board of Directors
  • Technology
    • Overview
    • Lysins
    • Amurins
    • Publications / Posters
    • Video Library
  • Pipeline
    • Overview
    • Exebacase
    • CF-370
    • Gram-negative Lysins
    • Amurins
  • Investors & Media
    • Overview
    • News / Events
    • Presentations
    • Company Information
    • Financial Information
    • Stock Data
    • SEC Filings
    • Corporate Governance
  • Careers
  • Contact Us

SEC Filings

Investors & Media

  • Home
  • Investors & Media
  • SEC Filings
Investors & Media

Investors & Media

  • Overview
  • News / Events
  • Presentations
  • Company Information
  • Financial Information
  • Stock Data
  • SEC Filings
  • Corporate Governance
  • Email Alerts
  • Tear Sheet
  • Contacts
  • RSS News Feed
Filter Filings:
Date Form Description Docs XBRL Pages
04/10/19 SC 13G/A Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions 12
04/04/19 4 Statement of changes in beneficial ownership of securities 2
04/02/19 DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material 4
04/02/19 8-K Current report filing
Related Documents
EX-10.1
EX-10.2
31
03/20/19 DEF 14A Definitive proxy statements 40
03/14/19 8-K Current report filing
Related Documents
EX-99.1
8
03/14/19 10-K Annual report pursuant to Section 13 and 15(d)
Related Documents
EX-23.1
EX-31.1
EX-31.2
EX-32.1
EX-32.2
126
02/26/19 8-K Current report filing 3
02/14/19 SC 13G/A Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions 13
02/14/19 SC 13G/A Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions 9
RSS
  • << Previous
  • 1...
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • ...44
  • Next >>
© 2021 ContraFect Corporation. All Rights Reserved.
Copyright Privacy Policy Expanded Access Policy Disclaimer Site Map
LinkedIn Twitter